Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Non Small Cell Lung Cancer × pemigatinib × 1 year × Clear all

Sponsor

Conditions

Cholangiocarcinoma 5 Acrocephalosyndactylia 5 Carcinoma, Transitional Cell 4 Neoplasm Metastasis 3 Recurrence 2 Urinary Bladder Neoplasms 1 Solid Tumor, Miscellaneous 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms, Unknown Primary 1 Myeloproliferative Disorders 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Acute 1 Glioma 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Eosinophilia 1 Endometrial Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 1 osimertinib 1 durvalumab 1 AZD 6244 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡